Nootropic

NSI-189 (Informational)

Also known as: NSI-189

Evidence

Experimental neurogenic compound being studied for depression. Not approved for use.

Primary uses

Neurogenesis
Depression research
Hippocampal growth

How it works

Stimulates hippocampal neurogenesis
Novel mechanism
Depression clinical trials

Dosage

Typical range: Clinical trials: 40-80 mg
Timing: N/A for public
With food: N/A
Duration: Not approved
Special populations: Clinical trial participants only

Forms

Research material

Safety

Common side effects

Unknown at large scale

Contraindications

Not for public use

Evidence notes

Experimental - not for general use

Grade D: Primarily pre-clinical or anecdotal; human efficacy not established.

Related in Nootropic

Check a full stack

Formulate's free interaction checker lets you paste in any combination of supplements and medications at once — every pairing flags severity, timing, and cited evidence.

Open the checker

Medical disclaimer. This page is educational and does not replace advice from a qualified healthcare provider.